Advanced thrombolytics for the treatment of stroke

Summarise with VIRAT
Authors: Veronika Surkovová
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Stroke is a serious medical condition that can be life-threatening or cause permanent damage. With the incidence of this disease continuing to rise, there is an increasing need for adequate and safe thrombolytic agents for treatment. Thisworkfocusesonmodifyingthestructureandpotentiallyimprovingthepropertiesofthemost commonly used thrombolytic agent today - alteplase. The aim of the work is to prepare an alteplase- polymer conjugate in order to prolong the effect of the thrombolytic agent itself. The preparation of the conjugate builds on the experience of colleagues from the Department of Biomedical Polymers at the Institute of Macromolecular Chemistry of the Czech Academy of Sciences, who worked on the modification of various functional groups of alteplase. This work focuses on the modification of alteplase in a new way, involving the oxidation of mannose units of the protein and the subsequent binding of alteplase to a suitable polymer carrier. Conjugation withthe polymer shouldprolongthe circulationof the thrombolytic agent in the bloodstream and thus its biological effect. One of the mechanisms could be the slowing downofthe biological degradationof alteplasein theliveras a result ofthe oxidation ofmannose units, which normally react with mannose receptors in hepatocytes without modification....

Fields of Study & Subjects

Advanced Drug Delivery Systems Polymer Surface Interaction Studies Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Digital Repository (National Repository of Grey Literature)
Publication date
1 January 2026
Language
CS
Document type
Thesis